1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow FENO: new trials by email Literature Review of FENO trials Research Report on FENO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) SEL, FIR, CILO - Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Completed | Gilead Sciences | 220 | 2016-06-13 | 2022-03-16 |
Non-alcoholic Fatty Liver Disease (1)
Gilead Sciences (1)
New Zealand (1) · United States (1)